Next-Generation CAR-T Therapies: Optimizing Opportunities and Operationalizing Patient-Centric Oncology Clinical Trials, Upcoming Webinar Hosted by Xtalks
In this webinar, learn about recent advancements in chimeric antigen receptor (CAR)-T cell therapy design and application. Attendees will discover the impact of next-generation CAR-T therapies on clinical trial operations such as reduced logistical complexities and improved patient experiences. The featured speakers will also discuss strategies for reducing the burden of trial participation in CAR-T studies.
TORONTO, Aug. 22, 2024 /PRNewswire-PRWeb/ -- Chimeric antigen receptor (CAR)-T cell therapies have become an important treatment modality for cancer but there remains a significant opportunity to enhance CAR-T therapies and leverage these therapeutics to address unmet clinical needs.
As these therapies evolve, their application is expanding beyond hematologic malignancies and advancements in science and technology are improving their efficacy, safety and durability of response. Next-generation CAR-T therapies have the potential to further transform the cancer treatment landscape by positively impacting outcomes, reducing toxicities and logistical complexity and enhancing patient accessibility and convenience.
In this webinar, the expert speakers will explore the latest innovations in CAR-T therapy and discuss key operational considerations aimed at improving the efficiency of clinical trials and enriching the experience of study participation for oncology patients.
Register for this webinar today to gain insights into how next-generation CAR-T therapies are transforming cancer care, focusing on enhancing patient outcomes and streamlining oncology clinical trials.
Join experts from Premier Research, Ashley Herrick, PhD, VP, Oncology Strategy; and Meera Belur, Executive Director, Program Strategy, for the live webinar on Tuesday, September 17, 2024, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Next-Generation CAR-T Therapies: Optimizing Opportunities and Operationalizing Patient-Centric Oncology Clinical Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com
View original content to download multimedia:https://www.prweb.com/releases/next-generation-car-t-therapies-optimizing-opportunities-and-operationalizing-patient-centric-oncology-clinical-trials-upcoming-webinar-hosted-by-xtalks-302228255.html
SOURCE Xtalks
Upcoming Life Sciences Events
- October 2024
- Copenhagen: LSX Nordic Congress
- Basel: BiotechX Europe 2024
- Amsterdam: World Drug Safety Congress Europe